ＪＣＲファーマ（4552）　JCR Announces Completion of Phase 1/2 Clinical Trial Notificationof TEMCELL HS Inj. (JR-031HIE)for the Indication of Neonatal Hypoxic Ischemic Encepha 2019/06/10
/-
読み込み中…